Deep tech VC fund specializing in synbio, biotech investments at pre-seed & seed stages.
Location
Los Angeles, CA, US
Founded
2018
MarsBio is a deep tech venture capital fund specializing in synthetic biology (synbio) and biotechnology investments. The firm focuses on pre-seed and seed stage companies, providing early-stage funding to innovative startups in these sectors. MarsBio's typical investment rounds include pre-seed and seed stages, positioning them as a crucial partner for nascent companies looking to develop groundbreaking technologies.
Notable portfolio companies include Karma Biotechnologies, which has raised $2.78 million, and Napigen, with $7.85 million in total funding. MarsBio's investment philosophy centers on supporting transformative technologies in the biotech and synbio spaces. The firm offers unique value-add services, leveraging deep industry expertise to help portfolio companies navigate technical challenges and accelerate growth. Key partners or decision-makers are not specified, but the firm's strategic focus and early-stage support make it a valuable ally for startups in the deep tech domain.
MarsBio - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Seed2 (66.7%)
Pre-Seed1 (33.3%)
Stage Mix
Seed 67%Pre-Seed 33%
Concentration shown as share of disclosed investments by stage.
